TRENTON, N.J. — Drug giant Pfizer Inc. has reached an $894 million deal to settle the bulk of the lawsuits over its withdrawn pain reliever Bextra, following the lead of rival Merck & Co., which is spending five times as much to settle Vioxx suits.
The Pfizer agreement also would end lawsuits over its popular Celebrex, the only one of the three _ all in the same class of anti-inflammatory drugs and all linked to elevated risk of heart attacks and...
]]>